Clinical Trial Update: Retrospective Study in a NSCLC M+ p

View source ↗

Summary

This document reports a completed retrospective study in patients with EGFR-mutated non-small cell lung cancer, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: EGFR Mutated Non-small Cell Lung Cancer Patients | Status: COMPLETED